There was no significant difference in intratumoral, tumor-stroma interface, and total PD-1+ cells, Foxp3+, and CD8+ T cells between the two groups, though these were numerically higher among tumors with PD-L1 TPS greater than or equal to 90% (Supplementary Fig. 11A–C). The gene discussed is CD8A; the disease is neoplasm.